Citations for
1RORA, SEMA3E
RORα modulates semaphorin 3E transcription and neurovascular interaction in pathological retinal angiogenesis.
Sun Y, Liu CH, Wang Z, Meng SS, Burnim SB, SanGiovanni JP, Kamenecka TM, Solt LA, Chen J.
FASEB J 31(10):4492-4502. doi: 10.1096/fj.201700172R. Epub 2017 Jun 23. 2017
2PLXND1, SEMA3E
Chemorepellent Semaphorin 3E Negatively Regulates Neutrophil Migration In Vitro and In Vivo.
Movassagh H, Saati A, Nandagopal S, Mohammed A, Tatari N, Shan L, Duke-Cohan JS, Fowke KR, Lin F, Gounni AS.
J Immunol 198(3):1023-1033. doi: 10.4049/jimmunol.1601093. Epub 2016 Dec 2. 2017
3PLXND1, SEMA3E
PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.
Rehman M, Gurrapu S, Cagnoni G, Capparuccia L, Tamagnone L.
PLoS One 11(10):e0164660. doi: 10.1371/journal.pone.0164660. eCollection 2016. Erratum in: PLoS One. 2016 Dec 9;11(12 ):e0168429. 2016
4PLXND1, SEMA3E
Sema3e/Plexin D1 Modulates Immunological Synapse and Migration of Thymocytes by Rap1 Inhibition.
Ueda Y, Kondo N, Ozawa M, Yasuda K, Tomiyama T, Kinashi T.
J Immunol 196(7):3019-31. doi: 10.4049/jimmunol.1502121. Epub 2016 Feb 26. 2016
5SEMA3E
Overexpression of Semaphorin-3E enhances pancreatic cancer cell growth and associates with poor patient survival.
Yong LK, Lai S, Liang Z, Poteet E, Chen F, van Buren G, Fisher W, Mo Q, Chen C, Yao Q.
Oncotarget 7(52):87431-87448. doi: 10.18632/oncotarget.13704. 2016
6GNRH1, SEMA3E
Dysfunctional SEMA3E signaling underlies gonadotropin-releasing hormone neuron deficiency in Kallmann syndrome.
Cariboni A, André V, Chauvet S, Cassatella D, Davidson K, Caramello A, Fantin A, Bouloux P, Mann F, Ruhrberg C.
J Clin Invest 125(6):2413-28. doi: 10.1172/JCI78448. Epub 2015 May 18. 2015
7PLXND1, SEMA3E, SH3BP1
An image-based RNAi screen identifies SH3BP1 as a key effector of Semaphorin 3E-PlexinD1 signaling.
Tata A, Stoppel DC, Hong S, Ben-Zvi A, Xie T, Gu C.
J Cell Biol 205(4):573-90. doi: 10.1083/jcb.201309004. Epub 2014 May 19. 2014
8PLXND1, SEMA3E
Therapeutic potential of semaphorin 3E for the treatment of choroidal neovascularization.
Suda K, Guo C, Oishi A, Ikeda S, Uemura A, Yoshimura N.
Invest Ophthalmol Vis Sci 55(8):4700-6. doi: 10.1167/iovs.14-14087. 2014
9SEMA3D, SEMA3E
Semaphorin 3d and semaphorin 3e direct endothelial motility through distinct molecular signaling pathways.
Aghajanian H, Choi C, Ho VC, Gupta M, Singh MK, Epstein JA.
J Biol Chem 289(26):17971-9. doi: 10.1074/jbc.M113.544833. Epub 2014 May 13. 2014
10SEMA3E
Semaphorin3E-induced inflammation contributes to insulin resistance in dietary obesity.
Shimizu I, Yoshida Y, Moriya J, Nojima A, Uemura A, Kobayashi Y, Minamino T.
Cell Metab 18(4):491-504. doi: 10.1016/j.cmet.2013.09.001. 2013
11SEMA3E
Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention.
Wanschel A, Seibert T, Hewing B, Ramkhelawon B, Ray TD, van Gils JM, Rayner KJ, Feig JE, O'Brien ER, Fisher EA, Moore KJ.
Arterioscler Thromb Vasc Biol 33(5):886-93. doi: 10.1161/ATVBAHA.112.300941. Epub 2013 Feb 21. 2013
12SEMA3E
A class III semaphorin (Sema3e) inhibits mouse osteoblast migration and decreases osteoclast formation in vitro.
Hughes A, Kleine-Albers J, Helfrich MH, Ralston SH, Rogers MJ.
Calcif Tissue Int 90(2):151-62. doi: 10.1007/s00223-011-9560-7. Epub 2012 Jan 7. 2012
13IQSEC1, SEMA3E
Phosphatidylinositol-4-phosphate 5-kinase and GEP100/Brag2 protein mediate antiangiogenic signaling by semaphorin 3E-plexin-D1 through Arf6 protein.
Sakurai A, Jian X, Lee CJ, Manavski Y, Chavakis E, Donaldson J, Randazzo PA, Gutkind JS.
J Biol Chem 286(39):34335-45. doi: 10.1074/jbc.M111.259499. Epub 2011 Jul 27. 2011
14PLXND1, SEMA3E
Semaphorin 3E-Plexin-D1 signaling regulates VEGF function in developmental angiogenesis via a feedback mechanism.
Kim J, Oh WJ, Gaiano N, Yoshida Y, Gu C.
Genes Dev 25(13):1399-411. doi: 10.1101/gad.2042011. 2011
15PLXND1, SEMA3E
Semaphorin 3E-Plexin-D1 signaling controls pathway-specific synapse formation in the striatum.
Ding JB, Oh WJ, Sabatini BL, Gu C.
Nat Neurosci 15(2):215-23. doi: 10.1038/nn.3003. 2011
16PLXND1, SEMA3E
Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.
Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.
J Clin Invest 120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano 2010
17PLXND1, SEMA3E
Specificity of sensory-motor connections encoded by Sema3e-Plxnd1 recognition.
Pecho-Vrieseling E, Sigrist M, Yoshida Y, Jessell TM, Arber S.
Nature 459(7248):842-6. Epub 2009 May 6. 2009
18PLXND1, SEMA3E
Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression.
Roodink I, Kats G, van Kempen L, Grunberg M, Maass C, Verrijp K, Raats J, Leenders W.
Am J Pathol 173(6):1873-81. Epub 2008 Oct 30. 2008
19SEMA3A, SEMA3B, SEMA3D, SEMA3E, SEMA3G
Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
Kigel B, Varshavsky A, Kessler O, Neufeld G.
PLoS One 3(9):e3287. 2008
20CHARGE, CHD7, CHARGE2, SEMA3E
CHARGE syndrome: an update.
Sanlaville D, Verloes A.
Eur J Hum Genet 15(4):389-99. Epub 2007 Feb 14. 2007
21SEMA3E, CHARGE2
SEMA3E mutation in a patient with CHARGE syndrome.
Lalani SR, Safiullah AM, Molinari LM, Fernbach SD, Martin DM, Belmont JW.
J Med Genet 41(7):e94. No abstract available. 2004
22CHARGE2, SEMA3E
CHARGE association with choanal atresia and inner ear hypoplasia in a child with a de novo chromosome translocation t(2;7)(p14;q21.11).
Martin DM, Sheldon S, Gorski JL.
Am J Med Genet 99(2):115-9. 2001
23SEMA3B, SEMA3E
Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines.
Christensen CR, Klingelhofer J, Tarabykina S, Hulgaard EF, Kramerov D, Lukanidin E.
Cancer Res 58(6):1238-44. 1998
24ADAMTS3, AKAP6, ALMS1, ANKRD28, AREL1, ARHGEF10, ARHGEF11, ARHGEF17, ARNT2, BAZ2A, CABIN1, CAST, CHD9, CIC, CLEC16A, CLOCK, CTNND1, DCLK1, DDX46, DIDO1, DNAH9, DNM3, DOCK3, DYNC1H1, ECM29, ENTPD4, EPB41L1, EZH1, FRMPD4, GCC2, HECW1, HERC2, HISPPD1, HUWE1, IGSF1, KAT6B, KHNYN, KIAA0319, KIAA0355, KIAA0379, KIF3B, KMT2B, LBA1, MADD, MAST4, MCF2L, MDN1, MTMR3, MYO6, N4BP3, NACAD, NRCAM, PCDH9, PCDHGA8, PCDHGC3, PDZD2, PER2, PFAS, PLEKHM1, PLXNB2, PRORP, PRUNE2, PTPRN2, RAPGEF2, RIMBP2, RIMS1, RIPOR2, RUSC2, SALL2, SEC16A, SEMA3C, SEMA3E, SETD1A, SFRS14, SNPH, SPECC1L, SPTBN2, SR140, SRCAP, SRRM2, SYNJ2, TECPR2, TLN2, TRIM66, TTC37, UBR2, WNK1, XPO6, ZBTB39, ZBTB5, ZFYVE16, ZFYVE26, ZMYM3, ZNF518A, ZNF609, ZNF629, ZNF646
Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.
Nagase T, Ishikawa K, Nakajima D, Ohira M, Seki N, Miyajima N, Tanaka A,Kotani H, Nomura N, Ohara O.
DNA Res 4(2):141-50. 1997
25SEMA3A, SEMA3B, SEMA3C, SEMA3D, SEMA3E, SEMA4B
Murine semaphorin D/collapsin is a member of a diverse gene family and creates domains inhibitory for axonal extension.
Puschel AW, Adams RH, Betz H.
Neuron 14(5):941-8. 1995